These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28282583)

  • 1. Control of immune escaped human papilloma virus is regained after therapeutic vaccination.
    Ma W; Melief CJ; van der Burg SH
    Curr Opin Virol; 2017 Apr; 23():16-22. PubMed ID: 28282583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives for the development of human papillomavirus vaccines and immunotherapy.
    Bermúdez-Humarán LG; Langella P
    Expert Rev Vaccines; 2010 Jan; 9(1):35-44. PubMed ID: 20021304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
    Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
    Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic human papillomavirus vaccination.
    Albers AE; Kaufmann AM
    Public Health Genomics; 2009; 12(5-6):331-42. PubMed ID: 19684445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-specific immune therapy: failure and hope.
    Nieto K; Gissmann L; Schädlich L
    Antivir Ther; 2010; 15(7):951-7. PubMed ID: 21041909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccines.
    Stanley MA
    Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Human Papilloma Virus in Penile Carcinogenesis and Preneoplastic Lesions: A Potential Target for Vaccination and Treatment Strategies.
    Diorio GJ; Giuliano AR
    Urol Clin North Am; 2016 Nov; 43(4):419-425. PubMed ID: 27717428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune evasion mechanisms of human papillomavirus: An update.
    Steinbach A; Riemer AB
    Int J Cancer; 2018 Jan; 142(2):224-229. PubMed ID: 28865151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
    Mora-García ML; Monroy-García A
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus targets crossroads in immune signaling.
    Tummers B; Burg SH
    Viruses; 2015 May; 7(5):2485-506. PubMed ID: 26008697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
    Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
    BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving forward with human papillomavirus immunotherapies.
    Çuburu N; Schiller JT
    Hum Vaccin Immunother; 2016 Nov; 12(11):2875-2880. PubMed ID: 27388123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus.
    Highleyman L
    BETA; 2007; 19(4):35-9. PubMed ID: 18069155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of human papillomavirus infection in lower genital tract neoplasia.
    Man S; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):701-14. PubMed ID: 11563868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma vaccination to adolescents.
    Levavi H
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):2-5. PubMed ID: 21037538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of HPV infection and related cancer through vaccination.
    Tran NP; Hung CF; Roden R; Wu TC
    Recent Results Cancer Res; 2014; 193():149-71. PubMed ID: 24008298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.